Literature DB >> 21988310

Changing epidemiology of meningococcal disease in Europe from the mid-20th to the early 21st Century.

Paula Kriz1, Heather Wieffer, Katsiaryna Holl, Mats Rosenlund, Sangeeta Budhia, Andrew Vyse.   

Abstract

The epidemiology of meningococcal disease in Europe since 1945 has shown fluctuations in incidence, serogroup distribution and case-fatality rate. Outbreaks and epidemics driven by the introduction of new virulent strains into Europe have occurred unpredictably. Epidemics associated with serogroups A and B have occurred in all regions of the continent. Additionally, there have been periods of increased outbreak frequency, such as those associated with serogroup C in the 1980s and 1990s, against an endemic disease incidence of around one to two cases per 100,000 population. Serogroup W135 disease was observed in the 1970s and again in 2000, while serogroup Y has recently emerged in Sweden and the Czech Republic. This article describes the changing epidemiology of meningococcal disease in Europe. An understanding of this is important for informed decision-making about different meningococcal vaccines that may be considered for use in Europe.

Entities:  

Mesh:

Year:  2011        PMID: 21988310     DOI: 10.1586/erv.11.117

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  13 in total

Review 1.  Meningococcal quadrivalent (serogroups A, C, W135 and Y) tetanus toxoid conjugate vaccine (Nimenrix™).

Authors:  Jamie D Croxtall; Sohita Dhillon
Journal:  Drugs       Date:  2012-12-24       Impact factor: 9.546

Review 2.  An epidemiological review of changes in meningococcal biology during the last 100 years.

Authors:  Anne Abio; Keith R Neal; Charles R Beck
Journal:  Pathog Glob Health       Date:  2013-12-19       Impact factor: 2.894

Review 3.  Epidemiology of invasive meningococcal disease in Greece, 2006-2016.

Authors:  Anastasia Flountzi; Theano Georgakopoulou; Sooria Balasegaram; Konstantinos Kesanopoulos; Athanasia Xirogianni; Anastasia Papandreou; Georgina Tzanakaki
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-08-15       Impact factor: 3.267

4.  Serogroup and Clonal Characterization of Czech Invasive Neisseria meningitidis Strains Isolated from 1971 to 2015.

Authors:  Zuzana Jandova; Martin Musilek; Zuzana Vackova; Jana Kozakova; Pavla Krizova
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

5.  Invasive meningococcal disease in the Veneto region of Italy: a capture-recapture analysis for assessing the effectiveness of an integrated surveillance system.

Authors:  Tatjana Baldovin; Roberta Lazzari; Silvia Cocchio; Patrizia Furlan; Chiara Bertoncello; Mario Saia; Francesca Russo; Vincenzo Baldo
Journal:  BMJ Open       Date:  2017-05-02       Impact factor: 2.692

6.  TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines.

Authors:  Irene Rivero-Calle; Jose Gómez-Rial; Louis Bont; Bradford D Gessner; Melvin Kohn; Ron Dagan; Daniel C Payne; Laia Bruni; Andrew J Pollard; Adolfo García-Sastre; Denise L Faustman; Albert Osterhaus; Robb Butler; Francisco Giménez Sánchez; Francisco Álvarez; Myrsini Kaforou; Xabier Bello; Federico Martinón-Torres
Journal:  Hum Vaccin Immunother       Date:  2020-08-05       Impact factor: 3.452

7.  A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2-10 years.

Authors:  Timo Vesikari; Aino Forstén; Dominique Boutriau; Véronique Bianco; Marie Van der Wielen; Jacqueline M Miller
Journal:  Hum Vaccin Immunother       Date:  2012-10-02       Impact factor: 3.452

8.  Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers.

Authors:  Timo Vesikari; Aino Forstén; Dominique Boutriau; Véronique Bianco; Marie Van der Wielen; Jacqueline M Miller
Journal:  Hum Vaccin Immunother       Date:  2012-10-02       Impact factor: 3.452

9.  A decade of invasive meningococcal disease surveillance in Poland.

Authors:  Anna Skoczyńska; Izabela Waśko; Alicja Kuch; Marcin Kadłubowski; Agnieszka Gołębiewska; Małgorzata Foryś; Marlena Markowska; Patrycja Ronkiewicz; Katarzyna Wasiak; Aleksandra Kozińska; Bożena Matynia; Waleria Hryniewicz
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

10.  Invasive meningococcal disease in Italy: from analysis of national data to an evidence-based vaccination strategy.

Authors:  S Igidbashian; L Bertizzolo; A Tognetto; C Azzari; P Bonanni; P Castiglia; M Conversano; S Esposito; G Gabutti; G Icardi; P L Lopalco; F Vitale; S Parisi; G Checcucci Lisi
Journal:  J Prev Med Hyg       Date:  2020-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.